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Abstract •  Background: Central 
areolar choroidal dystrophy 
(CACD) is a hereditary macular 
disorder of which the development 
is poorly understood •  Methods: 
One hundred and eight members of 
seven families with CACD under­
went ophthalmoJogical examination. 
If macular alterations were found or 
suspected, the patients underwent 
fluorescein angiography, elee- 
troretinography (ERG), electroocu­
lography (EOG) and tests of colour 
vision and visual field. CACD was 
divided into four stages: I, slight 
parafoveal changes of the pigment 
epithelium (RPE); II, RPE mottling 
encircling the fovea; III, additional 
atrophy of the choriocapillaris 
without central involvement; IV, as 
stage III with central involve­
ment. •  Results: In 60 eyes of 30 
patients, 8 with stage I, 12 with 
stage II, 18 with stage III and 22 
with stage IV CACD were found. 
The photopic ERG was subnormal 
in about half of the cases with stage 
II-IV. Colour vision tests revealed 
diminished red sensitivity and 
pseudoprotanomaly in stages I and
II and combined red-green and 
blue-yellow defect in stages III and 
IV. Parafoveal reduced sensitivity 
(stages I and II) and parafoveal and 
foveal reduced sensitivity (stages
III and IV) were found in the visual 
field tests. •  Conclusion: We de­
scribe and expand the stages of de­
velopment o f CACD. Early recogni­
tion of patients may have a great in­
fluence on their subsequent life.
Introduction
Central areolar choroidal dystrophy (CACD) is a heredi­
tary choroidal dystrophy of the posterior pole of the eye. 
The end-stage of this disease is characterized by the 
presence of a well-defined area of atrophy of the pho­
toreceptors, retinal pigment epithelium and underlying 
choriocapillaris in the macular region. In CACD a cen­
tral scotoma may gradually develop over several years in 
middle-aged patients. This generally leads to severe visu­
al impairment, to the level of counting fingers. In the 
majority of cases, this loss of vision will occur before the 
age of 60.
Sorsby [12] was the first to describe the genetic na­
ture of this condition. To date, only five families have
been described in the world literature with members of 
more than one generation affected [1-3, 6, 8, 10], along 
with six families where several siblings in one generation 
are afflicted [1-3, 11, 12]. On the basis of these reports, 
the inheritance of CACD appears to be either autosomal 
dominant or recessive. In addition, a number of sporadic 
cases have been reported [2, 3].
Almost all the patients described were first encoun­
tered by the authors in the atrophic end-stage of the dis­
ease. Only six patients were encountered with fundus 
alterations preceding the atrophic end-stage [1-3, 10, 
13].
When the chance to examine seven afflicted families 
occurred, the opportunity was seized to gain and system­
atize more information about this rare disease.
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Material and methods
When this investigation into the course of CACD was initiated in 
1987, several members of families Gu. and Ja., suffering from 
advanced CACD, were known in our department. In order to obtain 
as many cases as possible from these large families, 69 members 
of the two families were visited in 1988 and 1989. During visits, 
any visual complaints were noted and visual acuity was deter­
mined as accurately as possible. Fundus photographs were made 
by means of a portable KOWA fundus camera. When fundus alter­
ations were identified or suspected in ophthalmoscopy or after 
evaluation of the fundus photographs, the patients were asked to 
visit our clinic for further examination. Because the first results 
were encouraging, 39 family members of patients from five addi­
tional families with a possible autosomal-dominant irait o f CACD 
were also asked to attend our institution for ophthalmic examina­
tion. When fundus alterations were visible or suspected in exami­
nation with higher magnification, patients were asked to undergo 
fluorescein angiography. Because of the long duration of the elee- 
trophysiological tests and because abnormalities were not suspect­
ed in the very early stages of CACD, patients were only asked to 
undergo these examinations when abnormalities were detected in 
fluorescein angiography.
The retinal function tests were tested by electroretinography 
(ERG), electrooculography (EOG), colour vision tests and visual 
field tests. In the ERG tests, the patient faced a modified sphere of 
a Goldmann-Weekers adaptometer, lit by two 40-W incandescent 
lamps in order to furnish a Ganzfeld adaptation. A scleral contact 
lens equipped with the measuring electrodes had been inserted. A 
reference electrode was applied to the middle of the forehead,
while the patient was earthed by means of two ear-clip electrodes. 
A xenon flash was used for stimulation by flashes (flash luminance 
6.85 cd.s.m -2 photopic and 0.85 cd.s.m"2 scotopic). Measure­
ments were recorded at photopic and scotopic (after 12 min of dark 
adaptation) adaptation levels. Recorded electric potentials were 
plotted in a diagram against flash intensity. In the cases described 
in the following sections, the saturation level of the b-wave was 
noted under photopic circumstances. Recorded electric potentials 
were classified as abnormal when the a-wave did not exceed -
50 jiV and the b-wave did not exceed 100 (.lV in the photopic ERG 
and the b-wave did not exceed 150 p.V in the scotopic ERG. In 
EOG the patient faced the same sphere that was used for ERG 
measurements. Skin electrodes were placed near the cantili interni 
and externi of the eyes. After pre-adaptation at 100 lx for about
15 min, the sphere was made dark for 12 min and the EOG was 
recorded at intervals o f  2 min during this period. Then the sphere 
was adjusted to 2 500 lx and measurements were continued every 
minute for a further 15 min. The dark trough (Dt) was determined 
as the mean of the values between the 6 min and 12 min, and the 
light peak (Lp) was determined from the mean of the four maxi­
mum values during the light adaptation period. The Arden ratio 
(L p/D t ratio) was calculated, and values below 180 were classified 
as subnormal.
The Tokyo Medical College test (TMC) and the Farnsworth 
Panel D-15 test (D-15) or box 4 of the New CoIourTest (NCT 6/4) 
were used for screening colour vision. When the TMC testing 
result proved normal, the Ishihara test (1970 edition) was per­
formed, When a patient failed the TMC test, the American Optical 
Hardy Rand and Rittler test (HRR) was used. When the D-15 test 
result was - 5 0  |xV, or normal, the desaturated Panel D-15 test 
(D-8/2) was used; when the D-15 test result was abnormal, box 8
Fig. 1 Pedigrees of the seven 
families with CACD in two or 
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of the NCT (NCT 8/4) was used. If possible, the patient was asked 
to undergo the Farnsworth-Munsell 100 Hue test (100 Hue) and an 
anomaloscope examination (Nagel Model l í  or Neitz OT). When 
colour vision examination proved impossible, the patient was asked 
to denominate large coloured surfaces red, green, yellow and blue 
at the patient-preferred distance [9]. Static measurements were 
performed by means of the Rodenstock Peritest (single and m ulti­
ple stimuli with 17 luminance steps of 0.2 logU; background lum i­
nance 1 cd /m 2) and, in a few cases, the Oculus Friedman field 
analyser.
The pedigrees of the seven families are given in Fig. 1.
To describe the changes and to compare the different findings 
in our patients, according to observations made by Krill [7] and 
ourselves [5], we divide the development of CACD into four stages: 
Stage I: Doubtful or slight parafoveal pigmentary changes seen 
with contact lens or 60-D lens; fluorescein angiography shows a 
mottled hyperfluorescence that does not encircle the whole lovea. 
Stage II: Ophthalmoscopically evident alterations o f  the 
parafoveal pigment epithelium; hyperfluorescent spots, som e­
times intermingled with hypofluorescent areas, encircle the intact 
fovea more than 180 degrees in angiography.
Stage III: Same findings as in stage II, but also one or more areas 
of atrophy of choriocapillaris enhancing the visibility of the 
choroidal vessels throughout all phases of fluorescein angiogra­
phy; the fovea seems not affected.
Stage IV: Same findings as in stage III, but now the fovea is also 
affected by atrophy of the choriocapillaris.
Results
Although patients from several provinces in the south­
eastern part of the Netherlands are referred to the aca­
demic hospital of Nijmegen, it is striking that, at the time 
of examination, most affected family members (24 of the 
30 described) lived in the province of Limburg. It is also 
noticeable that in the case of six of the seven families 
concerned, the eldest traceable family members originat­
ed from this province. We could not find evidence that 
any of the families were related to each other. The geo­
graphical distribution of affected family members in 
shown in Fig. 2.
From the seven families concerned, 30 patients with 
various stages of CACD were identified. The first two 
stages of CACD could also be referred to as ’probable 
CACD’. In our patients who suffered from stage I or II of 
the disorder, no history or manifestations of systemic 
diseases, prolonged drug treatment or other ocular dis­
eases could explain the macular alterations adequately. 
The majority of patients revealed the same stage of 
CACD in both eyes. Different stages were found in six per­
sons (Gu. III-7, III-9, III-12; Te. IV -10; Li. III-3, III-4).
The number of eyes with CACD, by stage, are shown 
in Table 1. The gender ratio of the family members was 
1:1 (15 males, 15 females). The age distribution of the 
family members with CACD is giben in Table 2, where 
the total exceeds the number of 30 patients examined 
because those with two different stages of CACD are 
counted twice.
Seven male patients mentioned their first visual dis­
turbances as occurring between the ages of 37 and 55
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Fig. 2 Distribution of the family members from  the seven families
Table 1 Distribution o f  different stages (num ber of eyes) o f  
CACD within the families (no. of patients in parentheses)
Family Stage
I II III IV Total
Gu. _ 4 5 7 16(8)
Ja, 4 — 2 8 14(7)
Si. 2 — 2 — 4(2)
Sta. 2 — — 4 6(3)
Te. >. 1 3 3 2 8(4)
Ho. — 4 2 — 6(3)
Li — 1 4 1 6(3)
Total 8 12 18 22 60(30)
Table 2 Age distribution according to the various stages of CACD
Age Stage
(years)
I II III IV
2 0 -3 0 3 3 I
30 -40 1 1 1 —
4 0 -5 0 — 2 4 3
50-60 — — 4 5
60-70 — 1 2 5
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Table 3 Visual acuity (eyes) in various stages of CACD (CF 
counting fingers)
Visual acuity Stage
I II Ill IV
1.0 8 9 2
0 .6- 0.8 — 3 8 —
0.3-0.5 — — 5 —
0.1-0.25 — — 3 6
F ( at 3 -5  m) — — — 2
CF (at 0 .5 -2  m) — — — 14
years (mean 46 years). In the ten female patients who 
mentioned the age of onset» the range was from 25 to 52 
years (mean 45.2 years). Eight patients had no visual 
complaints, and in another eight the age of onset was 
unknown.
Although the relatively small group of patients makes 
statistical deductions difficult, there seemed to be no dif­
ference in the age of onset between male and female 
cases.
The visual acuities of the eyes of patients in the family 
studies and of sporadic cases, according to stage of 
CACD, are giben in Table 3.
In stage I, funduscopic changes were characterized by 
slight hypopigmentation in the parafoveolar area. A nor­
mal foveal reflex was observed. In all patients, slight pig­
mentary changes were not obvious in indirect ophthal­
moscopy. In three patients (Ja. III-3; Si, III-1 OS; Sta. 
II-l), this hypopigmentation could only be noted by 
means of a three-mirror contact lens, a 60-D lens or di­
rect ophthalmoscopy. In two patients (Ja. III-9; Si. Ill-1 
OD) these changes were still unclear or remained unob­
served using these examination methods, but fluorescein 
angiography proved the presence of pigmentary alter­
ations (Fig. 3). In stage II, hypopigmentation surround­
ing the fovea was already obvious in indirect ophthal­
moscopy. The diameter of the area of hypopigmentation 
varied from rather more than one disc diameter (Gu. IV- 
45; Te. III-5; Te. IV -10) in younger patients to more than 
two disc diameters in middle-aged patients (Gu. 11-17; 
Ho. I l l -1, III-2; Li. III-4). Hyperpigmentation, some­
times in a radial configuration, as could be seen in fluo­
rescein angiography (Fig. 4), was not obvious with either 
of the methods of funduscopy. Although stage III is char-
Table 4 Results of the pho­
topic and scotopic ERG and of Stage Photopic ERG
the EOG in patients in whom
these tests were performed a-wave (|iV)
I (n=4) - 5 2 .5 + 1 7 .9
II (n = 12) —63.3+  15.9
III (/2=12) -4 6 .3  ±14 .0
IV (« =  8) - 6 1 . 3 ±  16.2
Table 5 Results of colour vision tests in 40 eyes of 20 patients 
(.DRS diminished red sensitivity)
Stage
I II Ill IV
Normal 2 6
DRS (inch pseudoprotanomaly) 2 3 —  —
B -Y  defect (incl. DRS) — 3 4
R -G  defect (incl. DRS) 2
R -G  + B -Y  defect (incl. DRS) — — 12 6
Table 6 Results of visual field tests in 26 eyes of 13 patients
Stage
I II III IV
Normal 2 1 2
Paracentral reduced sensitivity 2 3 2 —
Central reduced sensitivity — 2 3 —
Pericentral scotoma — — 4 —
Central scotoma — 1 —
Pericentral and central scotoma — 1 4 1
acterized by one or more areas of atrophy of the chorio­
capillaris, the phenomenon was not always obvious when 
either funduscopy technique. In fluorescein angiogra­
phy, however, these lesions were obvious (Fig. 5). When 
the atrophy of the choriocapillaris and retinal pigment 
epithelium was visible in funduscopy, lesions showed a 
rather golden-yellowish aspect with increased visibility 
of the underlying choroidal vessels. In all cases with 
stage IV, the atrophy of pigment epithelium and chorio­
capillaris was observed in funduscopy and fluorescein 
angiography (Fig. 6).
Recorded electric potentials of the photopic and sco­
topic ERG are listed in Table 4. In stage I CACD these 
results were normal. Among 12 eyes with stage II, sub­
normal responses were found in 7 eyes in the photopic 
ERG and in 2 eyes in the scotopic ERG. In 12 eyes with 
stage III, subnormal responses were found in 4 and 3 eyes 
in the photopic and scotopic ERG, respectively. In 8 eyes 
with stage IV CACD, 4 subnormal responses were 
recorded in the photopic ERG and no abnormal results 
were found under scotopic conditions.
scotopic ERG EOG light-rise 
b-wave (jllV) b-wave (jaV)
142.5121.7  252.5 ±32.7  3 . 1 7 ± 0 .14
9 6 ,3 ± 3 3 .2  21 1.3 + 83.0 1 .91+0.19
100.8 + 37.0 207.1 ±95.1 2.43 ± 1 .43
83.8 + 29.5 230 ±55.5  2 .49±  1.27
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Fig. 3 Stage I CACD. Slight hypo- and hyperfluorescent spots are 
located in the lower quadrants of the parafoveal area
Fig. 4 Stage II CACD. Hyperfluorescent spots encircling the 
fo ve a
Fig. 5 Stage III CACD. Demarcated area of atrophy of the pig-
. In the
later phase of the angiogram, dye leaks from the border of chorio­
capillaris atrophy
Fig. 6 Stage IV CACD. Well-delineated area of atrophy o f  the 
pigment epithelium and choriocapillaris. The fovea is affected
ing pseudoprotanomaly; blue-yellow defect, including 
diminished red sensitivity) to defects found in macular
com ­
bined red-green and blue-yellow defect, including in 
both cases diminished red sensitivity).
The results of the static visual field tests are arranged 
in Table 6 in an order from reduced paracentral or central 
sensitivity to absolute paracentral and/or central scoto­
mas.
In 12 eyes with stage II, 13 eyes with stage III and 9 
eyes with stage IV CACD, a slightly abnormal L p /D t 
ratio was found in 4, 5 and 2 eyes, respectively.
The results of colour vision testing (Table 5) are ar­
ranged in order from defects found in macular damage 
with foveal fixation (diminished red sensitivity, includ-
Discussion
Sandvig [10] was the first to report CACD in four gener­
ations of one family, and stated that this was conclusive 
evidence for an autosomal dominant mode of heredity.
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Since his publication, only four other families have been 
reported [1, 4, 6, 8].
In this study, we present the clinical findings for the 
largest group of patients suffering from CACD ever de­
scribed. We examined 30 members of seven families in 
which two or more generations were affected, paying 
special attention to the stages of CACD preceding the 
atrophic end-stage.
Because in C ACD complaints about loss of vision de­
velop from the age of about 30-50 years, the generations 
in which visual impairment is to be expected must be 
scrutinized in order to determine how many members of 
one sibship are affected. Family Si. will not discussed 
further, because none of the relatives of patient Si. II-1 in 
earlier generations are known to have had a visual handi­
cap. Two deceased siblings of family Sta. will also not be 
taken into account, because they died young. This leaves 
44 siblings in six pedigrees: generation III in family Gu., 
II in family Ja., II in family Sta., Ill in family Te., II in 
family Ho. and II in family Li. In these generations, sib­
lings younger than 55 years of age were examined. They 
were at 50% risk assuming autosomal dominant inheri­
tance. Since 22 of these 44 (11 males and 11 females) 
indeed proved affected, these data proved fully compat­
ible with autosomal dominant heredity, with complete 
penetrance from the age of 50.
Thirty-six members aged between 20 and 40 years, 
from seven families, were examined. On the basis of au­
tosomal dominant heredity, with 100% penetrance, the 
expected number of symptomatic cases would be 18. 
However, nine members were found to be affected. This 
means that an age-dependent penetrance of approxi­
mately 50% was established for the age group of 20-40 
years.
CACD revealed itself to be a slowly progressive dis­
ease leading to a well-defined area of atrophy of the 
photoreceptors, pigment epithelium, choriocapillaris 
and smaller choroidal vessels confined in the posterior 
pole.
No very young patients with obvious macular 
changes, as described by Carr [1], were encountered. 
The first angiographic findings in or patients were small 
parafoveal window defects. In stage II the hyperfluores­
cent areas were concentrated around the fovea. Some­
times a radial configuration of hypofluorescent spots im­
itated a pattern dystrophy. Together with fluorescein an­
giography, colour vision tests (Table 5) and visual field 
tests (Table 6) are very helpful in diagnosing CACD in 
the early stages.
Visual deterioration developed in patients in their 
mid-40s. Visual acuity in patients with stage III CACD 
was in general only moderately affected, to a level of
0.8-0.6 (Table 3). Additional choriocapillaris atrophy, 
arising at this stage, led to paracentral scotomas, experi­
enced as inconvenient by the patients. Recorded electric 
potentials in the photopic ERG were reduced in about
50% of the patients in stages II and III (Table 4). The 
red-green defect often found in colour vision tests and a 
reduced central sensitivity in visual field testing indicate 
that, although atrophy of the choriocapillaris cannot yet 
be seen in the fovea, the central photoreceptors are al­
ready affected to some extent at this stage. In a very few 
patients from stage II onwards, the electric potentials in 
the scotopic ERG and the EOG values were diminished. 
However, these values were only slightly abnormal. 
Therefore, we could not confirm Carr’s suggestion [1] 
that this disease is probably more widespread than has 
been supposed.
On the basis of the findings in this study, the classifi­
cation of the disease was expanded as follows:
S t a g e  I: Age 20-40 years; visual acuity is normal; 
parafoveal pigmentary changes may be found in fundus­
copy, but are evident in fluorescein angiography; ERG 
and EOG are normal; diminished red sensitivity with 
pseudoprotanomaly and decreased parafoveal sensitivity 
may be found in colour vision and visual field tests, 
S ta g e  //: Age 20-50 years; sometimes visual complaints 
occur; parafoveal hypopigmentation evident in fundus­
copy; mottled hyperfluorescence in fluorescein angiog­
raphy; photopic ERG may be subnormal; colour vision 
and visual fields as in stage I.
S t a g e  l i t  Most patients are over 40 forty years of age; 
visual acuity is moderately reduced; parafoveal atrophy 
of the pigment epithelium occurs; atrophy of the chorio­
capillaris is not seen in funduscopy, but may be evident 
in fluorescein angiography; photopic and scotopic ERG 
and EOG values may be slightly subnormal; a blue-yel­
low colour vision defect is often accompanied by a red- 
green defect; parafoveal and foveal reduced sensitivity 
are demonstrated in visual field tests,
S t a g e  I V : Age 40-70 years; visual acuity is generally 
below 0.1; a demarcated central area of atrophy of pig­
ment epithelium and choriocapillaris is evident in fun­
duscopy and fluorescein angiography; ERG and EOG as 
in stage III; combined blue-yellow and red-green colour 
defect; central scotoma in visual field tests.
The question arises of whether the primary defect in 
CACD is located in the photoreceptor cells, in the pig­
ment epithelium or in the choriocapillaris. The small 
defects in the parafoveal pigment epithelium, the blue- 
yellow colour vision defects and the reduced parafoveal 
sensitivity in the visual field tests found in the early 
stages of CACD suggest that the primary defect is locat­
ed at the level of the retinal pigment epithelium. Recent­
ly, however, mutations in the retinal degeneration slow 
(rcls) gene, which codes for peripherin, a protein pre­
dominantly found in the membranes of the outer seg­
ments of rods and cones, have been implicated as a cause 
of macular dystrophy. This autosomal dominant dystro­
phy, found in three sibships, closely resembles CACD [ 14].
No therapy is available for CACD, and it seems unlike­
ly that one will be developed in the near future. Neverthe-
93
less, it is important to detect the early stages of CACD, Future research should be aimed at the localization 
because this diagnosis can exercise considerable influ- and subsequent isolation and examination of the gene or 
enee on the patient’s subsequent life. genes responsible for the natural course of CACD.
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